M. John Gill

28.9k total citations · 1 hit paper
395 papers, 11.3k citations indexed

About

M. John Gill is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, M. John Gill has authored 395 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Infectious Diseases, 143 papers in Epidemiology and 134 papers in Virology. Recurrent topics in M. John Gill's work include HIV/AIDS Research and Interventions (171 papers), HIV Research and Treatment (131 papers) and HIV/AIDS drug development and treatment (100 papers). M. John Gill is often cited by papers focused on HIV/AIDS Research and Interventions (171 papers), HIV Research and Treatment (131 papers) and HIV/AIDS drug development and treatment (100 papers). M. John Gill collaborates with scholars based in Canada, United States and United Kingdom. M. John Gill's co-authors include Hartmut B. Krentz, Christopher Power, HB Krentz, Andrew Phillips, Jonathan A C Sterne, Amy C. Justice, Peter Reiss, Deirdre L. Church, Antonella d’Arminio Monforte and Margaret May and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

M. John Gill

377 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

2002 1.2k citations Matthias Egger, Andrew Phillips et al. profile →

Peers

Countries citing papers authored by M. John Gill

Since Specialization

Citations

This map shows the geographic impact of M. John Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. John Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. John Gill more than expected).

Fields of papers citing papers by M. John Gill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. John Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. John Gill. The network helps show where M. John Gill may publish in the future.

Co-authorship network of co-authors of M. John Gill

This figure shows the co-authorship network connecting the top 25 collaborators of M. John Gill. A scholar is included among the top collaborators of M. John Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. John Gill. M. John Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Apollo: a comprehensive GPU-powered within-host simulator for viral evolution and infection dynamics across population, tissue, and cell 2025 ·Nature Communications ·(unknown), (unknown), Paul M. K. Gordon, Frank van der Meer, Tarah Lynch, M. John Gill, (unknown), A. P. Jason de Koning, Christian D. Huber, Guido van Marle, Alexander Platt, Quan Long	0
2	Changes in the Prevalence of Non-AIDS Conditions Among Hospitalized Persons With HIV in the United States and Canada, 2008–2018 2025 ·Clinical Infectious Diseases ·Thibaut Davy-Méndez, Sonia Napravnik, Brenna Hogan, Joseph J. Eron, Kelly A. Gebo, Keri N. Althoff, Richard D. Moore, Michael J. Silverberg, Michael A. Horberg, M. John Gill, Jonathan Colasanti, Ank E. Nijhawan, Maile Karris, Marina B. Klein, Raynell Lang, Catherine R. Lesko, George A. Yendewa, Gregory D. Kirk, Kathleen A. McGinnis, Stephen A. Berry, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study 2024 ·Open Forum Infectious Diseases ·Sahar Saeed, (unknown), (unknown), Erica E. M. Moodie, Joseph Cox, Curtis Cooper, M. John Gill, Valérie Martel‐Laferrière, Dimitra Panagiotoglou, Sharon Walmsley, Alexander Wong, Marina B. Klein	3
4	COVID-19 vaccine uptake among people with HIV: identifying characteristics associated with vaccine hesitancy 2023 ·Scientific Reports ·(unknown), M. John Gill, HB Krentz, (unknown), Brenda Beckthold, Kevin Fonseca, Jeffrey A. Bakal, Jacqueline M. McMillan, Jamil N. Kanji, Raynell Lang	2
5	Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine 2023 ·American Journal of Epidemiology ·(unknown), Michael G. Hudgens, Haidong Lu, Stephen R. Cole, Jessie K. Edwards, Adaora A. Adimora, Keri N. Althoff, Michael J. Silverberg, Peter F. Rebeiro, Viviane D. Lima, Vincent C. Marconi, Timothy R. Sterling, Michael A. Horberg, M. John Gill, Mari M. Kitahata, Richard D. Moore, Raynell Lang, Kelly A. Gebo, Charles S. Rabkin, Joseph J. Eron	1
6	HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis 2023 ·The Lancet HIV ·(unknown), Stefanie Hossmann, Suzanne M Ingle, Hajra Okhai, Katharina Kusejko, Johannes P. Mouton, Pantxika Bellecave, Ard van Sighem, Melanie Stecher, Antonella d’Arminio Monforte, M. John Gill, Caroline Sabin, Gary Maartens, Huldrych F. Günthard, Jonathan A C Sterne, Richard Lessells, Matthias Egger, Roger D. Kouyos	52
7	All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaboration 2023 ·The Lancet Public Health ·(unknown), Fiona Lampe, Suzanne M Ingle, Jonathan A C Sterne, Adam Trickey, M. John Gill, Vasileios Papastamopoulos, Linda Wittkop, Marc van der Valk, Maria Kitchen, Jodie L. Guest, Derek D. Satre, Gilles Wandeler, (unknown), Jessica L. Castilho, Heidi M. Crane, Colette Smith	4
8	Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States 2021 ·Annals of Epidemiology ·Parastu Kasaie, (unknown), Elizabeth Humes, (unknown), Jinbing Zhang, Michael J. Silverberg, Michael A. Horberg, Peter F. Rebeiro, Emily P. Hyle, Viviane D. Lima, Cherise Wong, M. John Gill, Kelly A. Gebo, Richard D. Moore, Mari M. Kitahata, Keri N. Althoff	7
9	LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care 2019 ·Open Forum Infectious Diseases ·Peter F. Rebeiro, Cathy A. Jenkins, Aihua Bian, Jordan E. Lake, Kassem Bourgi, Michael A. Horberg, Richard D. Moore, (unknown), Marina B. Klein, Joseph J. Eron, M. John Gill, Mari M. Kitahata, Sonia Napravnik, Michael J. Silverberg, Ángel M. Mayor, Amanda L. Willig, Michelle Floris-Moore, Timothy R. Sterling, John R. Koethe	13
10	Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada 2018 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Elizabeth L. Yanik, Raúl Ulises Hernández‐Ramírez, Qin Li, Haiqun Lin, Wendy A. Leyden, Romain Neugebauer, Michael A. Horberg, Richard D. Moore, William C. Mathews, Amy C. Justice, Nancy A. Hessol, Ángel M. Mayor, M. John Gill, John T. Brooks, Jing Sun, Keri N. Althoff, Eric A. Engels, Michael J. Silverberg, Robert Dubrow	13
11	Increasing incidence of syphilis among patients engaged in HIV care in Alberta, Canada: a retrospective clinic-based cohort study 2018 ·BMC Infectious Diseases ·Raynell Lang, Ron Read, Hartmut B. Krentz, (unknown), Mingkai Peng, Jennifer Gratrix, M. John Gill	18
12	Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV) 2015 ·Journal of Clinical and Experimental Neuropsychology ·Esther Fujiwara, (unknown), Scot E. Purdon, M. John Gill, Christopher Power	11
13	Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients 2013 ·EP Europace ·Vincent Probst, Frédéric Sacher, Nicolas Derval, Jean‐Baptiste Gourraud, Philippe Mabo, (unknown), Hervé Le Marec, M. John Gill	1
14	The Coding Causes of Death in HIV (CoDe) Project 2011 ·Epidemiology ·Justyna Kowalska, Nina Friis‐Møller, Ole Kirk, Wendy Bannister, Amanda Mocroft, Caroline Sabin, Peter Reiss, M. John Gill, Charlotte Lewden, Andrew Phillips, Antonella d’Arminio Monforte, Matthew Law, Jonathan A C Sterne, Stéphane De Wit, Jens Lundgren	111
15	An Evaluation of Motion JPEG 2000 for Video Archiving 2005 ·Archiving Conference ·(unknown), M. John Gill	2
16	The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001. 2003 ·PubMed ·Hartmut B. Krentz, M. Christopher Auld, M. John Gill	54
17	Phenotypic variations and switches in HIV isolated from the blood and the gastrointestinal tissues of patients with HIV-1 infection. HIV/GI Research Study Group. 1997 ·PubMed ·(unknown), Deirdre L. Church, M. John Gill	10
18	The MIPS Machine. 1982 ·John L. Hennessy, Norman P. Jouppi, M. John Gill, Forest Baskett, Alex Strong, Thomas R. Gross, Christopher Rowen, (unknown)	44
19	The Use of Attractive Fixed Points in Accelerating the Convergence of Limit-Periodic Continued Fractions 1975 ·Proceedings of the American Mathematical Society ·M. John Gill	3
20	Establishing family planning services in Kenya. 1970 ·PubMed ·N. R. E. Fendall, M. John Gill	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact